In this issue of Blood, Finn et al have taken a factor IX variant with increased specific activity associated with thrombophilia and used it to improve gene therapy of hemophilia B in dogs, and Cantore et al have shown similar results in mice.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1182/blood-2012-09-452821 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!